453 related articles for article (PubMed ID: 31330317)
21. IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation.
Garcia MN; Grasso D; Lopez-Millan MB; Hamidi T; Loncle C; Tomasini R; Lomberk G; Porteu F; Urrutia R; Iovanna JL
J Clin Invest; 2014 Nov; 124(11):4709-22. PubMed ID: 25250570
[TBL] [Abstract][Full Text] [Related]
22. The Loss of ATRX Increases Susceptibility to Pancreatic Injury and Oncogenic KRAS in Female But Not Male Mice.
Young CC; Baker RM; Howlett CJ; Hryciw T; Herman JE; Higgs D; Gibbons R; Crawford H; Brown A; Pin CL
Cell Mol Gastroenterol Hepatol; 2019; 7(1):93-113. PubMed ID: 30510993
[TBL] [Abstract][Full Text] [Related]
23. Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice.
Morris JP; Cano DA; Sekine S; Wang SC; Hebrok M
J Clin Invest; 2010 Feb; 120(2):508-20. PubMed ID: 20071774
[TBL] [Abstract][Full Text] [Related]
24. AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53.
Zhang Z; Li H; Deng Y; Schuck K; Raulefs S; Maeritz N; Yu Y; Hechler T; Pahl A; Fernández-Sáiz V; Wan Y; Wang G; Engleitner T; Öllinger R; Rad R; Reichert M; Diakopoulos KN; Weber V; Li J; Shen S; Zou X; Kleeff J; Mihaljevic A; Michalski CW; Algül H; Friess H; Kong B
Gastroenterology; 2021 Nov; 161(5):1601-1614.e23. PubMed ID: 34303658
[TBL] [Abstract][Full Text] [Related]
25. Acinar-to-Ductal Metaplasia (ADM): On the Road to Pancreatic Intraepithelial Neoplasia (PanIN) and Pancreatic Cancer.
Marstrand-Daucé L; Lorenzo D; Chassac A; Nicole P; Couvelard A; Haumaitre C
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373094
[TBL] [Abstract][Full Text] [Related]
26. Identification and manipulation of biliary metaplasia in pancreatic tumors.
Delgiorno KE; Hall JC; Takeuchi KK; Pan FC; Halbrook CJ; Washington MK; Olive KP; Spence JR; Sipos B; Wright CV; Wells JM; Crawford HC
Gastroenterology; 2014 Jan; 146(1):233-44.e5. PubMed ID: 23999170
[TBL] [Abstract][Full Text] [Related]
27. RBPJ Deficiency Sensitizes Pancreatic Acinar Cells to KRAS-Mediated Pancreatic Intraepithelial Neoplasia Initiation.
Pan L; Mulaw MA; Gout J; Guo M; Zarrin H; Schwarz P; Baumann B; Seufferlein T; Wagner M; Oswald F
Cell Mol Gastroenterol Hepatol; 2023; 16(5):783-807. PubMed ID: 37543088
[TBL] [Abstract][Full Text] [Related]
28. Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer.
Wauters E; Sanchez-Arévalo Lobo VJ; Pinho AV; Mawson A; Herranz D; Wu J; Cowley MJ; Colvin EK; Njicop EN; Sutherland RL; Liu T; Serrano M; Bouwens L; Real FX; Biankin AV; Rooman I
Cancer Res; 2013 Apr; 73(7):2357-67. PubMed ID: 23370328
[TBL] [Abstract][Full Text] [Related]
29. Docking Protein p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and Pancreatitis.
Costamagna A; Natalini D; Camacho Leal MDP; Simoni M; Gozzelino L; Cappello P; Novelli F; Ambrogio C; Defilippi P; Turco E; Giovannetti E; Hirsch E; Cabodi S; Martini M
Gastroenterology; 2022 Apr; 162(4):1242-1255.e11. PubMed ID: 34922945
[TBL] [Abstract][Full Text] [Related]
30. Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury.
Fendrich V; Jendryschek F; Beeck S; Albers M; Lauth M; Esni F; Heeger K; Dengler J; Slater EP; Holler JPN; Baier A; Bartsch DK; Waldmann J
Oncogene; 2018 Apr; 37(14):1845-1856. PubMed ID: 29367759
[TBL] [Abstract][Full Text] [Related]
31. ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis.
Wang L; Yang H; Zamperone A; Diolaiti D; Palmbos PL; Abel EV; Purohit V; Dolgalev I; Rhim AD; Ljungman M; Hadju CH; Halbrook CJ; Bar-Sagi D; di Magliano MP; Crawford HC; Simeone DM
Genes Dev; 2019 Jun; 33(11-12):641-655. PubMed ID: 31048544
[TBL] [Abstract][Full Text] [Related]
32. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice.
Habbe N; Shi G; Meguid RA; Fendrich V; Esni F; Chen H; Feldmann G; Stoffers DA; Konieczny SF; Leach SD; Maitra A
Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18913-8. PubMed ID: 19028870
[TBL] [Abstract][Full Text] [Related]
33. Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer.
Singh K; Pruski M; Bland R; Younes M; Guha S; Thosani N; Maitra A; Cash BD; McAllister F; Logsdon CD; Chang JT; Bailey-Lundberg JM
Lab Invest; 2021 Feb; 101(2):177-192. PubMed ID: 33009500
[TBL] [Abstract][Full Text] [Related]
34. Oral bacteria accelerate pancreatic cancer development in mice.
Saba E; Farhat M; Daoud A; Khashan A; Forkush E; Menahem NH; Makkawi H; Pandi K; Angabo S; Kawasaki H; Plaschkes I; Parnas O; Zamir G; Atlan K; Elkin M; Katz L; Nussbaum G
Gut; 2024 Apr; 73(5):770-786. PubMed ID: 38233197
[TBL] [Abstract][Full Text] [Related]
35. Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma.
Zhang W; Nandakumar N; Shi Y; Manzano M; Smith A; Graham G; Gupta S; Vietsch EE; Laughlin SZ; Wadhwa M; Chetram M; Joshi M; Wang F; Kallakury B; Toretsky J; Wellstein A; Yi C
Sci Signal; 2014 May; 7(324):ra42. PubMed ID: 24803537
[TBL] [Abstract][Full Text] [Related]
36. REG3A/REG3B promotes acinar to ductal metaplasia through binding to EXTL3 and activating the RAS-RAF-MEK-ERK signaling pathway.
Zhang H; Corredor ALG; Messina-Pacheco J; Li Q; Zogopoulos G; Kaddour N; Wang Y; Shi BY; Gregorieff A; Liu JL; Gao ZH
Commun Biol; 2021 Jun; 4(1):688. PubMed ID: 34099862
[TBL] [Abstract][Full Text] [Related]
37. Differential Cell Susceptibilities to Kras
Shi C; Pan FC; Kim JN; Washington MK; Padmanabhan C; Meyer CT; Kopp JL; Sander M; Gannon M; Beauchamp RD; Wright CV; Means AL
Cell Mol Gastroenterol Hepatol; 2019; 8(4):579-594. PubMed ID: 31310834
[TBL] [Abstract][Full Text] [Related]
38. Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model.
Hidalgo-Sastre A; Brodylo RL; Lubeseder-Martellato C; Sipos B; Steiger K; Lee M; von Figura G; Grünwald B; Zhong S; Trajkovic-Arsic M; Neff F; Schmid RM; Siveke JT
Am J Pathol; 2016 Nov; 186(11):2934-2944. PubMed ID: 27639167
[TBL] [Abstract][Full Text] [Related]
39. Inactivation of
Saeki K; Qiu W; Friedman RA; Pan S; Lu J; Ichimiya S; Chio IIC; Shawber CJ; Kitajewski J; Hu J; Su GH
Cancer Res Commun; 2022 Dec; 2(12):1601-1616. PubMed ID: 36970723
[TBL] [Abstract][Full Text] [Related]
40. Hematopoietic progenitor kinase 1 inhibits the development and progression of pancreatic intraepithelial neoplasia.
Wang H; Moniruzzaman R; Li L; Ji B; Liu Y; Zuo X; Abbasgholizadeh R; Zhao J; Liu G; Wang R; Tang H; Sun R; Su X; Tan TH; Maitra A; Wang H
J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37140994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]